Compounds > temozolomide
Page last updated: 2024-08-16

temozolomide and dabrafenib

temozolomide has been researched along with dabrafenib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bordeaux, JS; Koon, HB; Palathinkal, DM; Sharma, TR1
Arnold, A; Braun, R; Dummer, R; Guckenberger, M; Hunger, RE; Lindenblatt, N; Michielin, O; Mihic-Probst, D; Najafi, Y; Siano, M; von Moos, R1
Aaby, JB; Bastholt, L; Donia, M; Duval, L; Ellebaek, E; Hoejberg, L; Køhler, UH; Schmidt, H; Svane, IM; Øllegaard, TH1
Franken, MG; Gheorghe, M; Haanen, JBAG; Leeneman, B; Uyl-de Groot, CA; van Baal, PHM1

Reviews

3 review(s) available for temozolomide and dabrafenib

ArticleYear
Current systemic therapies for melanoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Bridged-Ring Compounds; Dacarbazine; Humans; Imidazoles; Indoles; Interferon-alpha; Interleukin-2; Ipilimumab; Melanoma; Oximes; Platinum Compounds; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Skin Neoplasms; Sulfonamides; Taxoids; Temozolomide; Vemurafenib

2014
The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.
    Swiss medical weekly, 2016, Volume: 146

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Chemotherapy, Adjuvant; Dacarbazine; Dermatologic Surgical Procedures; Humans; Imidazoles; Indoles; Ipilimumab; Lymph Node Excision; Melanoma; Neoplasm Staging; Nivolumab; Oximes; Practice Guidelines as Topic; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy; Skin Neoplasms; Sulfonamides; Switzerland; Temozolomide; Vemurafenib

2016
A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma.
    European journal of cancer (Oxford, England : 1990), 2019, Volume: 123

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Benzimidazoles; Cancer Vaccines; Carboplatin; Dacarbazine; gp100 Melanoma Antigen; Humans; Hydrazines; Imidazoles; Interleukin-2; Ipilimumab; Lenalidomide; Melanoma; Network Meta-Analysis; Nitrosourea Compounds; Nivolumab; Organophosphorus Compounds; Oximes; Paclitaxel; Piperidines; Progression-Free Survival; Proportional Hazards Models; Pyridones; Pyrimidinones; Skin Neoplasms; Sorafenib; Survival Rate; Temozolomide; Treatment Outcome; Vemurafenib

2019

Other Studies

1 other study(ies) available for temozolomide and dabrafenib

ArticleYear
The real-world impact of modern treatments on the survival of patients with metastatic melanoma.
    European journal of cancer (Oxford, England : 1990), 2019, Volume: 108

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Denmark; Female; Humans; Imidazoles; Ipilimumab; Male; Melanoma; Nivolumab; Oximes; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Skin Neoplasms; Survival Rate; Temozolomide

2019